BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dalhoff A. Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. Clin Microbiol Rev 2014;27:753-82. [PMID: 25278574 DOI: 10.1128/CMR.00022-14] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Bos AC, van Holsbeke C, de Backer JW, van Westreenen M, Janssens HM, Vos WG, Tiddens HA. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough? PLoS One 2015;10:e0118454. [PMID: 25734630 DOI: 10.1371/journal.pone.0118454] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
2 Son YJ, Miller DP, Weers JG. Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics 2021;13:1528. [PMID: 34575603 DOI: 10.3390/pharmaceutics13091528] [Reference Citation Analysis]
3 Sass A, Everaert A, Van Acker H, Van den Driessche F, Coenye T. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics. Antimicrob Agents Chemother 2018;62:e02607-17. [PMID: 29439968 DOI: 10.1128/AAC.02607-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kumar M, Rao M, Mathur T, Barman TK, Joshi V, Chaira T, Singhal S, Pandya M, Al Khodor S, Upadhyay DJ, Masuda N. Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model. Front Microbiol 2021;12:603151. [PMID: 33967970 DOI: 10.3389/fmicb.2021.603151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shetty N, Zhang Y, Park H, Zemlyanov D, Shah D, He A, Ahn P, Mutukuri TT, Chan HK, Zhou QT. Surface Composition and Aerosolization Stability of an Inhalable Combinational Powder Formulation Spray Dried Using a Three-Fluid Nozzle. Pharm Res 2020;37:219. [PMID: 33037471 DOI: 10.1007/s11095-020-02937-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Burgener EB, Sweere JM, Bach MS, Secor PR, Haddock N, Jennings LK, Marvig RL, Johansen HK, Rossi E, Cao X, Tian L, Nedelec L, Molin S, Bollyky PL, Milla CE. Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis. Sci Transl Med 2019;11:eaau9748. [PMID: 30996083 DOI: 10.1126/scitranslmed.aau9748] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 20.0] [Reference Citation Analysis]
7 Kruizinga MD, Birkhoff WAJ, van Esdonk MJ, Klarenbeek NB, Cholewinski T, Nelemans T, Dröge MJ, Cohen AF, Zuiker RGJA. Pharmacokinetics of intravenous and inhaled salbutamol and tobramycin: An exploratory study to investigate the potential of exhaled breath condensate as a matrix for pharmacokinetic analysis. Br J Clin Pharmacol 2020;86:175-81. [PMID: 31658494 DOI: 10.1111/bcp.14156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Keating CL, Zuckerman JB, Singh PK, McKevitt M, Gurtovaya O, Bresnik M, Marshall BC, Saiman L. Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation. Antimicrob Agents Chemother 2021;65:e02327-20. [PMID: 33318007 DOI: 10.1128/AAC.02327-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST. Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ. Antimicrob Agents Chemother 2018;62:e01231-18. [PMID: 30297366 DOI: 10.1128/AAC.01231-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gur D, Glinert I, Aftalion M, Vagima Y, Levy Y, Rotem S, Zauberman A, Tidhar A, Tal A, Maoz S, Ber R, Pass A, Mamroud E. Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model. Front Microbiol 2018;9:741. [PMID: 29740404 DOI: 10.3389/fmicb.2018.00741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Schwarz C, Procaccianti C, Mignot B, Sadafi H, Schwenck N, Murgia X, Bianco F. Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging. Pharmaceutics 2021;13:2051. [PMID: 34959333 DOI: 10.3390/pharmaceutics13122051] [Reference Citation Analysis]
12 Müsken M, Klimmek K, Sauer-Heilborn A, Donnert M, Sedlacek L, Suerbaum S, Häussler S. Towards individualized diagnostics of biofilm-associated infections: a case study. NPJ Biofilms Microbiomes 2017;3:22. [PMID: 28970943 DOI: 10.1038/s41522-017-0030-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
13 Wenzler E, Fraidenburg DR, Scardina T, Danziger LH. Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clin Microbiol Rev 2016;29:581-632. [PMID: 27226088 DOI: 10.1128/CMR.00101-15] [Cited by in Crossref: 54] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
14 Ehrmann S, Chastre J, Diot P, Lu Q. Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care. Ann Intensive Care 2017;7:78. [PMID: 28766281 DOI: 10.1186/s13613-017-0301-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]